Novo Nordisk rises after full data for new weight loss pill Source: Seekingalpha
Browsing: full
Travere gains on full FDA approval for kidney drug Filspari Source: Seekingalpha
Travere gains on full FDA approval for kidney drug Filspari Source: Seekingalpha
Travere gains on full FDA approval for kidney drug Filspari Source: Seekingalpha
Alnylam falls after full data for heart drug that can rival Pfizer’s Source: Seekingalpha
Alnylam falls after full data for heart drug that can rival Pfizer’s Source: Seekingalpha
Alnylam falls after full data for heart drug that can rival Pfizer’s Source: Seekingalpha
Cosmos Health (NASDAQ:COSM) has regained compliance with Listing Rule, in connection with the submitting of its 2023 Annual Report on Form 10-K and its monetary outcomes for…
Cosmos Health (NASDAQ:COSM) has regained compliance with Listing Rule, in connection with the submitting of its 2023 Annual Report on Form 10-K and its monetary outcomes for…
Cosmos Health (NASDAQ:COSM) has regained compliance with Listing Rule, in connection with the submitting of its 2023 Annual Report on Form 10-K and its monetary outcomes for…